Journal of Cardiovascular Pharmacology
Targeting Lipoprotein(a) in Cardiovascular Disease: Emerging Therapies and Clinical Implications
ReviewInterventions
- Oral inhibitor of lp(a) particle assembly
- Pelacarsen
- Lipid and ceramide metabolism
- Lipoprotein
- Atherosclerotic cardiovascular disease
- Humans
The paper
Azienda Ospedaliera Regionale San Carlo; San Raffaele Roma University
Journal of Cardiovascular Pharmacology, 9 Oct 2026
